About Jayin Pharmaceuticals Private Limited
Data last updated:
Jayin Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24230UP2019PTC209696. Its GSTIN is 10AAECJ6972F1ZP (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amar Nath Choudhary and Rachna Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lucknow, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.19 Lakh, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹6.76 Lakh (net margin -13.5%) and EBITDA of -₹6.69 Lakh (EBITDA margin -13.3%). Revenue has grown at a compounded annual rate (CAGR) of 318% over three years and 242% over five years.
For more details, the company can be reached via its website jayin.ltd.
Company details
CIN history
Jayin Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230BR2019PTC044242. The current CIN is U24230UP2019PTC209696, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230UP2019PTC209696 | Current |
| U24230BR2019PTC044242 | Previous |
Contact details
Jayin Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered Address1/142 Virat Khand, Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jayin Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Jayin Pharmaceuticals Private Limited, buy the company report.
Financials of Jayin Pharmaceuticals Private Limited
FY 2025 filings availableJayin Pharmaceuticals Private Limited reported revenue of ₹50.19 Lakh (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 242% over five years, including 23% growth in the latest year. EBITDA fell 673% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -13.3% | ||||
| Net Profit Margin | -13.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jayin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jayin Pharmaceuticals Private Limited
Jayin Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amar Nath Choudhary Also directs: Lifekind Pharmaceuticals Private Limited | Director | 25 Nov 2019 | 6 Years 11 Months | Current |
| Rachna Kumari | Director | 25 Nov 2019 | 6 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Jayin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jayin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jayin Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECJ6972F1ZP | Bihar | Active | 14 Sep 2022 |
To see the full GST registrations and return filing status of Jayin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jayin Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Amar Nath Choudhary was appointed as Director on 25 Nov 2019.
Frequently asked questions
Jayin Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 November 2019 (7+ years old) and is registered under CIN U24230UP2019PTC209696.
Jayin Pharmaceuticals has 2 current directors:
- Amar Nath Choudhary - Director
- Rachna Kumari - Director
The latest financial statements of Jayin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Jayin Pharmaceuticals is 10AAECJ6972F1ZP, registered in Bihar.
The CIN (Corporate Identification Number) of Jayin Pharmaceuticals is U24230UP2019PTC209696. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jayin Pharmaceuticals was incorporated on 25 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
Amar Nath Choudhary was appointed as Director on 25 Nov 2019. Rachna Kumari was appointed as Director on 25 Nov 2019.
Jayin Pharmaceuticals can be reached through the website jayin.ltd. Its registered office is in Lucknow, Uttar Pradesh, India.
The registered office of Jayin Pharmaceuticals is at 1142 Virat Khand, Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
Jayin Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.